Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Villarroya

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|January 27, 2005
Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analoguesRafael León, José Marco-Contelles, Antonio G García, et al.
Expert Opinion on Investigational Drugs|November 29, 2007
An update on the pharmacology of galantamineMercedes Villarroya, Antonio G García, José Marco-Contelles, et al.
Cardiovascular Drug Reviews|July 12, 2005
Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking propertiesMercedes Villarroya, Manuela G López, Ricardo de Pascual, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 23, 2011
Measurement of Ca²+ entry using ⁴⁵Ca²+Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 21, 2006
Measurement of Ca2+ entry using 45Ca2+Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Pflugers Archiv : European Journal of Physiology|August 21, 2017
Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compoundsCristobal de Los Rios, Maria F Cano-Abad, Mercedes Villarroya, et al.
European Journal of Pharmacology|September 15, 2004
Differences in the vascular selectivity and tolerance between the NO donor/beta-blocker PF9404C and nitroglycerinAna Ruiz-Nuño, Arancha Rosado, Antonio G García, et al.
European Journal of Medicinal Chemistry|October 13, 2006
Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicalsJosé Marco-Contelles, Rafael León, Manuela G López, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptorsEsperanza Arias, Sonia Gallego-Sandín, Mercedes Villarroya, et al.
Chemical Reviews|January 13, 2006
Synthesis and pharmacology of galantamineJosé Marco-Contelles, Maria do Carmo Carreiras, Carolina Rodríguez, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|January 27, 2005
Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analoguesRafael León, José Marco-Contelles, Antonio G García, et al.
Expert Opinion on Investigational Drugs|November 29, 2007
An update on the pharmacology of galantamineMercedes Villarroya, Antonio G García, José Marco-Contelles, et al.
Cardiovascular Drug Reviews|July 12, 2005
Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking propertiesMercedes Villarroya, Manuela G López, Ricardo de Pascual, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 23, 2011
Measurement of Ca²+ entry using ⁴⁵Ca²+Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 21, 2006
Measurement of Ca2+ entry using 45Ca2+Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Pflugers Archiv : European Journal of Physiology|August 21, 2017
Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compoundsCristobal de Los Rios, Maria F Cano-Abad, Mercedes Villarroya, et al.
European Journal of Pharmacology|September 15, 2004
Differences in the vascular selectivity and tolerance between the NO donor/beta-blocker PF9404C and nitroglycerinAna Ruiz-Nuño, Arancha Rosado, Antonio G García, et al.
European Journal of Medicinal Chemistry|October 13, 2006
Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicalsJosé Marco-Contelles, Rafael León, Manuela G López, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptorsEsperanza Arias, Sonia Gallego-Sandín, Mercedes Villarroya, et al.
Chemical Reviews|January 13, 2006
Synthesis and pharmacology of galantamineJosé Marco-Contelles, Maria do Carmo Carreiras, Carolina Rodríguez, et al.
Pageof 5